41. CRP projekt : vpliv epidemije covid-19 na obvladovanje raka v SlovenijiTina Žagar, Sonja Tomšič, Mario Fafangel, Mateja Krajc, Ana Mihor, Vesna Zadnik, 2020, objavljeni strokovni prispevek na konferenci Ključne besede: obvladovanje raka, covid-19, javno zdravje
Objavljeno v DiRROS: 07.04.2021; Ogledov: 1100; Prenosov: 316
 Celotno besedilo (99,24 KB) |
42. |
43. |
44. Priporočila za obravnavo bolnic z rakom zunanjega spolovilaSebastjan Merlo, Nina Kovačević, Barbara Šegedin, Tina Arnež, Sonja Bebar, Barbara Gazić, Andreja Gornjec, Borut Kobal, Manja Šešek, Maja Pakiž, Erik Škof, Iztok Takač, Vesna Zadnik, Helena Barbara Zobec Logar, 2020, strokovni članek Ključne besede: zunanje spolovilo, rak (medicina), diagnostika, zdravljenje
Objavljeno v DiRROS: 18.03.2021; Ogledov: 1251; Prenosov: 399
Celotno besedilo (745,40 KB) |
45. 70 years of the Slovenian Cancer Registry : knowledge, quality, applicabilityAmela Duratović Konjević, Vesna Škrbec, Sonja Tomšič, Katarina Lokar, Nika Bric, Vesna Zadnik, 2020, ni določena Ključne besede: onkologija, rak (medicina), registri, zgodovinski pregledi
Objavljeno v DiRROS: 16.03.2021; Ogledov: 1417; Prenosov: 437
Celotno besedilo (6,30 MB) |
46. 70 let Registra raka Republike Slovenije : znanje, kakovost, uporabnostAmela Duratović Konjević, Vesna Škrbec, Sonja Tomšič, Katarina Lokar, Nika Bric, Vesna Zadnik, 2020, strokovna monografija Ključne besede: onkologija, rak (medicina), registri, zgodovinski pregledi
Objavljeno v DiRROS: 16.03.2021; Ogledov: 1281; Prenosov: 581
Celotno besedilo (6,47 MB)
Gradivo ima več datotek! Več... |
47. Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in slovenia : a cohort studyŽiga Rotar, Petra Svetina, Matija Tomšič, Alojzija Hočevar, Sonja Praprotnik, 2020, izvirni znanstveni članek Povzetek: Objectives: This study aimed to assess the risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) treated with any of the commercially available tumour necrosis factor inhibitors (TNFis) in Slovenia. Design: This is a cohort, registry (biorx.si) cross-linked with the Slovenian National TB Registry. Setting: National, involving all Slovenian rheumatology centres (six secondary and two secondary/tertiary). Participants: 2429 patients with RA, AS or PsA exposed to at least one TNFi participated in the study. Primary and secondary outcome measures: The primary outcome measures were age-adjusted and sex-adjusted TB incidence rates (IRs) and the standardised incidence ratios (SIRs) compared with the general population exploring different TNFi exposure windows. The secondary outcome measures were a detailed characterisation of the national latent tuberculosis infection (LTBI) screening and TB chemoprophylaxis protocol implementation. Results: Among the 2429 patients exposed to at least one TNFi for a total of 10 445 (49% RA, 33% AS and 18% PsA) person-years (PY), 99% completed LTBI screening and 6% required TB chemoprophylaxis. Six RA (three adalimumab, three certolizumab), two PsA (two golimumab) and zero AS patients developed TB. Five out of eight had miliary TB, three out of eight had pulmonary TB and two patients died. The age-standardised and sex-standardised TB IR (95% CI) per 100 000 PYs/SIRs (95% CI) compared with the general Slovenian population for the current TNFi exposure were 52 (0 to 110)/6.7 (0.6 to 80), 47 (0 to 110)/6.1 (0.3 to 105), 45 (0 to 109)/5.8 (0.3 to 112) overall, in RA and PsA, respectively. Conclusions: The TB IR in the Slovenian patients with RA, AS and PsA treated with TNFi was comparable with TB IRs in TB non-endemic countries with less than a tenth of the patients requiring TB chemoprophylaxis.
Ključne besede: epidemiology, rheumatology, tuberculosis
Objavljeno v DiRROS: 12.11.2020; Ogledov: 1206; Prenosov: 573
Celotno besedilo (445,46 KB) |
48. Assessing the protective role of alpine forests against rockfall at regional scaleChristian Scheidl, Micha Heiser, Sonja Vospernik, Elisabeth Lauss, Frank Perzl, Andreas Kofler, Karl Kleemayr, Francesco Bettella, Emanuele Lingua, Matteo Garbarino, Mitja Skudnik, Daniel Trappmann, Frédéric Berger, 2020, izvirni znanstveni članek Povzetek: Worldwide, mountain forests represent a significant factor in reducing rockfall risk over long periods of time on large potential disposition areas. While the economic value of technical protection measures against rockfall can be clearly determined and their benefits indicated, there is no general consensus on the quantification of the protective effect of forests. Experience shows that wherever there is forest, the implementation of technical measures to reduce risk of rockfall might often be dispensable or cheaper, and large deforestations (e.g. after windthrows, forest fires, clear-cuts) often show an increased incidence of rockfall events. This study focussed on how the protective effect of a forest against rockfall can be quantified on an alpine transregional scale. We therefore estimated the runout length, in terms of the angle of reach, of 700 individual rockfall trajectories from 39 release areas from Austria, Germany, Italy and Slovenia. All recorded rockfall events passed through forests which were classified either as coppice forests or, according to the CORINE classification of land cover, as mixed, coniferous or broadleaved dominated high forest stands. For each individual rockfall trajectory, we measured the forest structural parameters stem number, basal area, top height, ratio of shrub to high forest and share of coniferous trees. To quantify the protective effect of forests on rockfall, a hazard reduction factor is introduced, defined as the ratio between an expected angle of reach without forest and the back-calculated forest-influenced angles of reach. The results show that forests significantly reduce the runout length of rockfall. The highest reduction was observed for mixed high forest stands, while the lowest hazard reduction was observed for high forest stands dominated either by coniferous or broadleaved tree species. This implies that as soon as one tree species dominates, the risk reduction factor becomes lower. Coppice forests showed the lowest variability in hazard reduction. Hazard reduction due to forests increases, on average, by 7% for an increase in the stem number by 100 stems per hectare. The proposed concept allows a global view of the effectiveness of protective forests against rockfall processes and thus enable to value forest ecosystem services for future transregional assessments on a European level. Based on our results, general cost%benefit considerations of nature-based solutions against rockfall, such as protective forests as well as first-order evaluations of rockfall hazard reduction effects of silvicultural measures within the different forest types, can be supported.
Ključne besede: protection forests, rockfall, European Alps, rockfall hazard
Objavljeno v DiRROS: 13.07.2020; Ogledov: 1625; Prenosov: 960
Celotno besedilo (2,03 MB)
Gradivo ima več datotek! Več... |
49. Postopki za obravnavo bolnic z rakom materničnega vratuBarbara Šegedin, Sonja Bebar, Olga Cerar, Branko Cvjetičanin, Barbara Gazić, Brigita Gregorič, Urška Ivanuš, Borut Kobal, Manja Šešek, Leon Meglič, Maja Pakiž, Nina Kovačević, Špela Smrkolj, Erik Škof, Iztok Takač, Helena Barbara Zobec Logar, 2019, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Ključne besede: ONKOLOGIJA-STOJIŠČE, onkologija, ginekologija
Objavljeno v DiRROS: 10.06.2020; Ogledov: 1823; Prenosov: 563
Celotno besedilo (717,48 KB) |
50. Priporočila za obravnavo bolnic z rakom materničnega vratuBarbara Šegedin, Darja Arko, Sonja Bebar, Olga Cerar, Branko Cvjetičanin, Barbara Gazić, Brigita Gregorič, Urška Ivanuš, Borut Kobal, Manja Šešek, Leon Meglič, Maja Pakiž, Nina Kovačević, Špela Smrkolj, Erik Škof, Iztok Takač, Helena Barbara Zobec Logar, 2019, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Ključne besede: diagnostika, kirurško zdravljenje, radikalno zdravljenje, kemoterapija, sledenje pacientov, nosečnice, zdravstvena obravnava, recidiv, paliativna oskrba, epidemiologija, histopatologija, smernice
Objavljeno v DiRROS: 10.06.2020; Ogledov: 1900; Prenosov: 630
Celotno besedilo (984,88 KB) |
